FindTrial
Sign In

A real-world study of conventional treatment modalities for patients with differentiated thyroid cancer

A real-world study of conventional treatment modalities for patients with differentiated thyroid cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400081312
Enrollment
Unknown
Registered
2024-02-28
Start date
2024-03-01
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Differentiated thyroid cancer

Interventions

Differentiated thyroid cancer (Cohort A/ Cohort B):None

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 100 Years

Inclusion criteria

Inclusion criteria: Cohort A Inclusion criteria: ? Patients with thyroid cancer who underwent total thyroidectomy in West China Hospital of Sichuan University from January 2010 to November 2023; ? Patients with differentiated thyroid carcinoma (including follicular carcinoma of thyroid and papillary carcinoma of thyroid) confirmed by pathology after surgery Cohort B Inclusion criteria: ? Patients with thyroid cancer who underwent total thyroidectomy at West China Hospital of Sichuan University in December 2023 or later; ? Patients with differentiated thyroid carcinoma (including follicular carcinoma of thyroid and papillary carcinoma of thyroid) confirmed by pathology after surgery; ? Agree to participate in the study and be willing to undergo regular follow-up

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
Recurrence-free survival;Overall survival;Progression free survival;—

Countries

China

Contacts

Public ContactRui Huang

West China Hospital of Sichuan University

huang_rui@scu.edu.cn+86 189 8060 5781

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026